Scroll back to top

Posted November 12, 2018

MNG Answers™

MNG Answers™

MNG is driven to help our healthcare partners, patients, and families find the answers they need when it comes to a diagnosis. MNG has solutions allowing economical reflex options to further investigate negative or inconclusive results.

MNG Variant Investigation Program (MNG VIP™)

No-cost familial testing for qualifying variants found in NGS and single gene testing performed at MNG.

  • VUS interpretation or identifying de novo variants in the proband
  • Applies to both single nucleotide or copy number variants
  • Results provided through an updated proband report

Negative Panel Reflex To MNG Exome™ Options

NGS panels are useful diagnostic tools, but they fail to identify the cause of disease in a significant percentage of cases. When further testing is re­quired, MNG makes it easy to add WES to the existing proband sample.

  • MNG Panel Negative reflex to MNG Exome™ Proband Only – $1,995
  • MNG Panel Negative reflex to MNG Exome™ Trio – $2,995

MNG Exome™ Reassessment

Complete data re-evaluation, not just classification updates to previously reported variants, including copy number changes and newly identified variants.

  • No-cost reassessment once per year
  • Eligible 6 months after report date
  • Applies to previous and future MNG Exome™ tests

Negative MNG Exome™ Reflex Options

Whole Exome Sequencing can provide a genetic diagnosis for about 25% of patients, leaving a large portion of those tested with inconclusive results. Whole Genome Sequencing allows assessment of noncoding genomic regions, while transcriptome analysis, applied along with MNG Exome™ or MNGenome® testing allows for functional assessment of variants affecting regulatory regions.

  • MNG Transcriptome™
  • Gene-Specific RNA seq – $845
  • Full Transcriptome – $1,485
  • MNGenome®
  • Proband – $4,400
  • Trio- $6,900

Tags:


Related News


April 9, 2018

MNG Expands Global Reach With Several New Distributors

MNG Laboratories is pleased to announce the signing of several key international distributor agreements in Asia, Latin America and Eastern Europe.